MeiraGTx rises
Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders. Now it’s on the cusp of its first regulatory approval. Each year ...
Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene therapy, data that are prompting the biotech to seek accelerated approval ...
In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against the other gene therapy stocks. Gene therapy is referred to as a medical technique that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback